From the Director
Support from the James Graham Brown Foundation, Kosair Charities, the Louisville community and the University of Louisville’s President have fostered the emergence of a leading Cancer Center that is making critical contributions to clinical care in the region and, through pioneering research, to cancer patients throughout the world. Much of the research that has been performed in our laboratories over the past 15 years under the leadership of Dr. Donald Miller and Dr. Jason Chesney is reaching clinical trials in humans, where new cancer drugs and diagnostics are being tested.
The goals of our groundbreaking translational research programs are to bring laboratory discoveries to patients in the clinic.
To achieve this, we are:
- Identifying, developing, and rigorously evaluating new tools for the treatment and detection of cancer by expanding research in experimental therapeutics.
- Strengthening cutting-edge research in tumor immunology, which harnesses the power of the immune system to fight cancer.
- Building a program in cancer prevention and control to identify lifestyle, environmental, and genetic factors that influence cancer susceptibility and progression.
- Introducing promising drugs, vaccines, and diagnostic procedures directly to patients through clinical trials.